BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 19641863)

  • 1. Human parthenogenetic embryonic stem cells: one potential resource for cell therapy.
    Hao J; Zhu W; Sheng C; Yu Y; Zhou Q
    Sci China C Life Sci; 2009 Jul; 52(7):599-602. PubMed ID: 19641863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histocompatible embryonic stem cells by parthenogenesis.
    Kim K; Lerou P; Yabuuchi A; Lengerke C; Ng K; West J; Kirby A; Daly MJ; Daley GQ
    Science; 2007 Jan; 315(5811):482-6. PubMed ID: 17170255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell therapies to treat muscular dystrophy: progress to date.
    Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
    BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induced pluripotent stem cells (iPS cells)].
    Germain D
    Pathol Biol (Paris); 2009; 57(7-8):555-9. PubMed ID: 19880264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of mouse embryonic stem cell lines from zona-free nuclear transfer embryos.
    Kobolak J; Bodo S; Rungsiwiwut R; Meng Q; Adorjan M; Virutamasen P; Techakumphu M; Dinnyes A
    Cell Reprogram; 2010 Feb; 12(1):105-13. PubMed ID: 20132018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial reprogramming of human somatic cells to generate pluripotent stem cells: a possible alternative to the controversial use of human embryonic stem cells.
    Romano G
    Drug News Perspect; 2008 Oct; 21(8):440-5. PubMed ID: 19034350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
    Rezanejad H; Matin MM
    Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regenerative therapy for post-stroke patients].
    Yamashita T; Abe K
    Nihon Rinsho; 2016 Apr; 74(4):661-5. PubMed ID: 27333756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional full-term placentas formed from parthenogenetic embryos using serial nuclear transfer.
    Hikichi T; Ohta H; Wakayama S; Wakayama T
    Development; 2010 Sep; 137(17):2841-7. PubMed ID: 20659973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient derivation of embryonic stem cells from nuclear transfer and parthenogenetic embryos derived from cryopreserved oocytes.
    Sung LY; Chang CC; Amano T; Lin CJ; Amano M; Treaster SB; Xu J; Chang WF; Nagy ZP; Yang X; Tian XC
    Cell Reprogram; 2010 Apr; 12(2):203-11. PubMed ID: 20677934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation potential of histocompatible parthenogenetic embryonic stem cells.
    Lengerke C; Kim K; Lerou P; Daley GQ
    Ann N Y Acad Sci; 2007 Jun; 1106():209-18. PubMed ID: 17360798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling.
    Koch P; Kokaia Z; Lindvall O; Brüstle O
    Lancet Neurol; 2009 Sep; 8(9):819-29. PubMed ID: 19679274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of embryonic stem cells: limitations of and alternatives to inner cell mass harvest.
    Das S; Bonaguidi M; Muro K; Kessler JA
    Neurosurg Focus; 2008; 24(3-4):E4. PubMed ID: 18341407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concise review: parthenote stem cells for regenerative medicine: genetic, epigenetic, and developmental features.
    Daughtry B; Mitalipov S
    Stem Cells Transl Med; 2014 Mar; 3(3):290-8. PubMed ID: 24443005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-specific pluripotent stem cells: promises and challenges.
    Müller R; Lengerke C
    Nat Rev Endocrinol; 2009 Apr; 5(4):195-203. PubMed ID: 19352317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stem cells: therapeutic applications and experimental techniques].
    Mikkers HM; Hoeben RC
    Ned Tijdschr Geneeskd; 2011; 155(47):A3565. PubMed ID: 22129808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sources of stem cells for regenerative medicine.
    Hipp J; Atala A
    Stem Cell Rev; 2008; 4(1):3-11. PubMed ID: 18286392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of the retinal potential of embryonic stem cells and amniotic fluid-derived stem cells.
    Decembrini S; Cananzi M; Gualdoni S; Battersby A; Allen N; Pearson RA; Ali RR; De Coppi P; Sowden JC
    Stem Cells Dev; 2011 May; 20(5):851-63. PubMed ID: 20939691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.